Delivery Order HHSN272201700040I-75N93024F00002

Award Date 6/25/24
Potential Completion Date 6/24/27
Potential Value $6.7M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Galveston, TX 77555, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The $3,465,763 cost-reimbursement task order is part of a larger indefinite delivery contract (IDC) valued at $146.3 million that UTMB holds with NIAID to provide preclinical services for infectious disease research. Under this task order, UTMB will conduct studies...
This federal contract award is for a task order issued under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The prime contractor is the University of Texas Medical Branch (UTMB) at Galveston, a state government entity and educational institution with extensive experience supporting federal agencies in areas such as infectious disease research, clinical trials, and emergency preparedness. The...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Texas Medical Branch at Galveston (UTMB) for preclinical models of infectious diseases research. The contract has a ceiling value of $1,745,363.00 and a period of performance ending on September 2, 2025. It is a delivery order issued under NIAID's larger Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract, a single-award...
This federal contract award is for the University of Texas Medical Branch at Galveston (UTMB) to provide a range of services related to biomedical research and healthcare to the National Institute of Allergy and Infectious Diseases (NIAID). The award is a Delivery Order under NIAID's Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract, with a ceiling value of $1,508,894.41. The contract does not have a set-aside designation. As a major academic health center, UTMB has...
This is a task order award under a larger indefinite delivery contract (IDC) held by the University of Texas Medical Branch at Galveston (UTMB) with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. The task order, valued at $5,130,964.00, is for work related to TASK A02 and will support the university's research and development efforts across various areas, including the development of animal models, specialized reagents, and...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston (UTMB), a U.S. state government medical institution and educational institution. The $417,060 delivery order was for task order funding under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, with a...
The University of Texas Medical Branch at Galveston (UTMB) was awarded a $4.26 million delivery order against the National Institute of Allergy and Infectious Diseases' (NIAID) Preclinical Models of Infectious Diseases multiple award indefinite delivery/indefinite quantity (IDIQ) contract vehicle for 2017-2024. The contract calls for UTMB to establish small animal models for screening countermeasures against the 2019 novel coronavirus (SARS-CoV-2) that causes COVID-19. Funding comes from the...
This is a $1,179,674.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB). The contract is for pre-clinical models of infectious diseases research and is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle, which has a total ceiling value of $2,706,323.34. UTMB, a...
This federal contract award is for a delivery order under the "NIAID Animal Models of Infectious Diseases 2010-2017" indefinite delivery contract held by the University of Texas Medical Branch at Galveston (UTMB). The $100,000 order supports unspecified work related to TAS::75 0885::TAS, which was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). As a state-controlled institution of higher learning,...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to the University of Texas Medical Branch at Galveston (UTMB). The $393,542.08 delivery order falls under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract supports UTMB's provision of pre-clinical research services, such as testing...

This federal contract award to the University of Texas Medical Branch at Galveston (UTMB) is for a task order under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The $6,739,837 task order is for the development of medical countermeasures and animal models for biosafety level 4 (BSL-4) pathogens. The work will be performed in Galveston, Texas, and the contract has a final completion date of June 24, 2027. UTMB is a state-controlled institution of higher learning with extensive experience supporting federal agencies through research and development efforts, particularly in high-containment laboratory research and infectious disease modeling. This contract is not set-aside and is a cost-type award with no fee.

Generated 5/23/25, 10:12 AM